Hot Investor Mandate: New Venture Capital Fund Seeks Early-Stage Therapeutics, Medical Device, and Diagnostics Investment Opportunities in USA and Canada

13 Oct

A venture capital fund in the process of raising USD 150 million will be used to invest in around ten to twelve early-stage startups. The fund will primarily look to participate in Series A fundraising but is open to earlier rounds as well. The firm will only participate in equity investments with an initial check size between USD 3 million and USD 7 million. The fund will primarily invest in companies that are based in the United States but is open to considering opportunities in Canada as well.

The firm is interested in investing in companies within the therapeutics, diagnostics, and medical technology sectors. The fund is modality agnostic and open to all companies within these sectors but will not consider investments in digital health. The firm will primarily seek to invest in therapeutics in the pre-clinical and Phase I stages of development as well as devices and diagnostics that are in development and clinical. The fund will invest in all classes of medical devices including Class II (510k) and Class III (PMA). The firm is disease agnostic and will consider companies across all indications including orphan diseases.

The firm prefers to work with experienced management teams that are made up of passionate and driven people developing great science. The fund is an active investor that will require a board seat and may act as either a lead or co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: